Dear Editor,
We read with interest the study Modulation of Hb-O 2 affinity to improve hypoxemia in COVID-19 patients, by Woyke et al. [1]. The opinion paper discussed the potential impact of a nutritional intervention in patients with Coronavirus-19 (COVID-19), where supplementing 5-Hydroxymethylfurfural (5-HMF) could increase haemoglobin-oxygen (Hb-O2) affinity. Typically, hypercapnia, acidosis and hyperthermia shift the oxygen dissociation curve (ODC) to the right, reducing Hb-O2 affinity and worsening hypoxaemia. This scenario could justify the rationale for the conclusion that a nutritional intervention shifting the ODC to the left could improve oxygenation in hypoxaemic respiratory failure [2], such as in COVID-19 patients.
The scenario presented is physiologically sound and based on evidence available at the time of publication. However, a recent study showed that Hb-O2 affinity was actually higher in mechanically ventilated COVID-19 patients [average(SD); p50 23.4 (3.1) mmHg) compared to the normal value for p50 of 26.7 mmHg, as well as compared to a control group of critically ill patients [p50 24.6 (5.4) mmHg] [3]. In addition, COVID-19 is characterised by shunt and dead space – across the severity of oxygenation - that differ from the typical acute respiratory distress syndrome [4,5]. This observed left-shift of the ODC may be a compensatory mechanism that, while facilitating oxygen uptake in the pulmonary circulation and arterial oxygenation, could reduce the rate of peripheral oxygen unloading, although the rate of oxygen unloading may be increased if/when peripheral carbon dioxide and temperature are elevated.
The proposed nutritional intervention remains a potentially effective approach, especially in the absence of significant side effects, pending some important considerations. An optimum degree of ODC left-shift needs to be identified in terms of balancing the benefits of more rapid pulmonary oxygen uptake and arterial oxygenation with the associated reduced rate of peripheral oxygen unloading – therefore the modulation of other factors such as pH may be relevant. The nutritional intervention modality and timing needs to be determined: it may be beneficial only to a subset of COVID-19 patients with a defined clinical phenotype [5] or perhaps earlier in the disease. Here lies the difficulty particularly if patients are asymptomatic or do not perceive hypoxaemia. Finally, the overall outcome of interest and the effect size need to be defined, particularly with reference to the efficacy in the reduction of p50.
Despite the complexity of the proposed therapeutic nutritional intervention and the characterisation of the associated physiological responses, its implementation might be worth investigating.
Author contributions
FF, DV and LC conceived the study, interpreted the data and approved the final manuscript.
Conflict of interest
The authors declare no competing interests.
References
- 1.Woyke S., Rauch S., Ströhle M., Gatterer H. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients. Clin Nutr. 2020 doi: 10.1016/j.clnu.2020.04.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yalcin O., Cabrales P. Increased hemoglobin O 2 affinity protects during acute hypoxia. Am J Physiol Heart Circ Physiol. 2012 doi: 10.1152/ajpheart.00078.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Vogel D.J., Formenti F., Retter A.J., Vasques F., Camporota L. A left shift in oxyhaemoglobin dissociation curve in patients with severe COVID-19. Br J Haematol. 2020 doi: 10.1111/bjh.17128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vasques F., Sanderson B., Formenti F., Shankar-Hari M., Camporota L. Physiological dead space ventilation, disease severity and outcome in ventilated patients with hypoxaemic respiratory failure due to coronavirus disease 2019. Intensive Care Med. 2020 doi: 10.1007/s00134-020-06197-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gattinoni L., Coppola S., Cressoni M., Busana M., Rossi S., Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020 doi: 10.1164/rccm.202003-0817LE. [DOI] [PMC free article] [PubMed] [Google Scholar]